Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I

被引:5
|
作者
Yousefi, Maria [1 ]
Sudarsan, Arun Kumar Annan [1 ,2 ]
Gaba, Amit [1 ]
Chelico, Linda [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
[2] Ctr Commercializat Regenerat Med CCRM, 661 Univ Ave 1002, Toronto, ON M5G 1M1, Canada
来源
VIRUSES-BASEL | 2023年 / 15卷 / 02期
基金
加拿大健康研究院;
关键词
restriction factor; HIV-1; APOBEC3; HEPATITIS-B-VIRUS; CBF-BETA; RESTRICTION; RNA; POLYMORPHISMS; HYPERMUTATION; DIMERIZATION; DEAMINATION; INHIBITION; EVOLUTION;
D O I
10.3390/v15020463
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The seven human APOBEC3 enzymes (APOBEC3A through H, excluding E) are host restriction factors. Most of the APOBEC3 enzymes can restrict HIV-1 replication with different efficiencies. The HIV-1 Vif protein combats APOBEC3-mediated restriction by inducing ubiquitination and degradation in the proteasome. APOBEC3F and APOBEC3G can hetero-oligomerize, which increases their restriction capacity and resistance to Vif. Here we determined if APOBEC3C, APOBEC3F, or APOBEC3G could hetero-oligomerize with APOBEC3H haplotype I. APOBEC3H haplotype I has a short half-life in cells due to ubiquitination and degradation by host proteins, but is also resistant to Vif. We hypothesized that hetero-oligomerization with APOBEC3H haplotype I may result in less Vif-mediated degradation of the interacting APOBEC3 and stabilize APOBEC3H haplotype I, resulting in more efficient HIV-1 restriction. Although we found that all three APOBEC3s could interact with APOBEC3H haplotype I, only APOBEC3F affected APOBEC3H haplotype I by surprisingly accelerating its proteasomal degradation. However, this increased APOBEC3F levels in cells and virions in the absence or presence of Vif and enabled APOBEC3F-mediated restriction of HIV-1 in the presence of Vif. Altogether, the data suggest that APOBEC3 enzymes can co-regulate each other at the protein level and that they cooperate to ensure HIV-1 inactivation rather than evolution.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] APOBEC3A, APOBEC3B, and APOBEC3H Haplotype 2 Restrict Human T-Lymphotropic Virus Type 1
    Ooms, Marcel
    Krikoni, Aikaterini
    Kress, Andrea K.
    Simon, Viviana
    Muenk, Carsten
    JOURNAL OF VIROLOGY, 2012, 86 (11) : 6097 - 6108
  • [32] APOBEC3D and APOBEC3F Potently Promote HIV-1 Diversification and Evolution in Humanized Mouse Model
    Sato, Kei
    Takeuchi, Junko S.
    Misawa, Naoko
    Izumi, Taisuke
    Kobayashi, Tomoko
    Kimura, Yuichi
    Iwami, Shingo
    Takaori-Kondo, Akifumi
    Hu, Wei-Shau
    Aihara, Kazuyuki
    Ito, Mamoru
    An, Dong Sung
    Pathak, Vinay K.
    Koyanagi, Yoshio
    PLOS PATHOGENS, 2014, 10 (10)
  • [33] Dual Functionality of HIV-1 Vif in APOBEC3 Counteraction and Cell Cycle Arrest
    Salamango, Daniel J.
    Harris, Reuben S.
    FRONTIERS IN MICROBIOLOGY, 2021, 11
  • [34] Structural Insights into HIV-1 Vif-APOBEC3F Interaction
    Nakashima, Masaaki
    Ode, Hirotaka
    Kawamura, Takashi
    Kitamura, Shingo
    Naganawa, Yuriko
    Awazu, Hiroaki
    Tsuzuki, Shinya
    Matsuoka, Kazuhiro
    Nemoto, Michiko
    Hachiya, Atsuko
    Sugiura, Wataru
    Yokomaku, Yoshiyuki
    Watanabe, Nobuhisa
    Iwatani, Yasumasa
    JOURNAL OF VIROLOGY, 2016, 90 (02) : 1034 - 1047
  • [35] Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction
    Gaba, Amit
    Yousefi, Maria
    Bhattacharjee, Shreoshri
    Chelico, Linda
    JOURNAL OF VIROLOGY, 2025, 99 (01)
  • [36] The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches
    Richards, Christopher
    Albin, John S.
    Demir, Ozlem
    Shaban, Nadine M.
    Luengas, Elizabeth M.
    Land, Allison M.
    Anderson, Brett D.
    Holten, John R.
    Anderson, John S.
    Harki, Daniel A.
    Amaro, Rommie E.
    Harris, Reuben S.
    CELL REPORTS, 2015, 13 (09): : 1781 - 1788
  • [37] The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches
    Demir, Ozlem
    Richards, Christopher
    Albin, John S.
    Shaban, Nadine M.
    Anderson, Brett D.
    Amaro, Rommie E.
    Harris, Reuben S.
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 385A - 385A
  • [38] Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H
    Fumiaki Ito
    Ana L. Alvarez-Cabrera
    Kyumin Kim
    Z. Hong Zhou
    Xiaojiang S. Chen
    Nature Communications, 14
  • [39] Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F
    Yang, Yiliang
    Guo, Fei
    Cen, Shan
    Kleiman, Lawrence
    VIROLOGY, 2007, 365 (01) : 92 - 100
  • [40] A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity
    Zhen, Anjie
    Wang, Tao
    Zhao, Ke
    Xiong, Yong
    Yu, Xiao-Fang
    JOURNAL OF VIROLOGY, 2010, 84 (04) : 1902 - 1911